-
1
-
-
37149028925
-
Immune-mediated thrombocytopenias: Focus on chronic immune thrombocyto-penic purpura
-
10.1053/j.seminhematol.2007.11.001
-
R McMillan 2007 Immune-mediated thrombocytopenias: focus on chronic immune thrombocyto-penic purpura Semin Hematol 44 1 2 10.1053/j.seminhematol. 2007.11.001
-
(2007)
Semin Hematol
, vol.44
, pp. 1-2
-
-
McMillan, R.1
-
2
-
-
34547106040
-
Immune thrombocytopenic purpura
-
10.1016/j.hoc.2007.06.007 17666288
-
B Psaila JB Bussel 2007 Immune thrombocytopenic purpura Hematol Oncol Clin North Am 21 743 759 10.1016/j.hoc.2007.06.007 17666288
-
(2007)
Hematol Oncol Clin North Am
, vol.21
, pp. 743-759
-
-
Psaila, B.1
Bussel, J.B.2
-
3
-
-
51649127854
-
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura
-
1:CAS:528:DC%2BD1cXpvVOktLw%3D 10.1182/blood-2008-01-135335 18420827
-
J Yu S Heck V Patel J Levan Y Yu JB Bussel, et al. 2008 Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura Blood 112 1325 1328 1:CAS:528:DC%2BD1cXpvVOktLw%3D 10.1182/blood-2008-01-135335 18420827
-
(2008)
Blood
, vol.112
, pp. 1325-1328
-
-
Yu, J.1
Heck, S.2
Patel, V.3
Levan, J.4
Yu, Y.5
Bussel, J.B.6
-
4
-
-
16844365788
-
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self
-
1:CAS:528:DC%2BD2MXisVyitLY%3D 10.1038/ni1178 15785760
-
S Sakaguchi 2005 Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self Nat Immunol 6 345 352 1:CAS:528:DC%2BD2MXisVyitLY%3D 10.1038/ni1178 15785760
-
(2005)
Nat Immunol
, vol.6
, pp. 345-352
-
-
Sakaguchi, S.1
-
5
-
-
38349128561
-
Is splenectomy still the gold standard for the treatment of chronic ITP?
-
10.1002/ajh.21109 17994550
-
F Rodeghiero M Ruggieri 2008 Is splenectomy still the gold standard for the treatment of chronic ITP? Am J Hematol 83 91 10.1002/ajh.21109 17994550
-
(2008)
Am J Hematol
, vol.83
, pp. 91
-
-
Rodeghiero, F.1
Ruggieri, M.2
-
6
-
-
38349124539
-
Splenectomy for immune thrombocytopenic purpura: Surgery for the 21st century
-
10.1002/ajh.21029 17722078
-
JP Dolan BC Sheppard TG Deloughery 2008 Splenectomy for immune thrombocytopenic purpura: surgery for the 21st century Am J Hematol 83 93 96 10.1002/ajh.21029 17722078
-
(2008)
Am J Hematol
, vol.83
, pp. 93-96
-
-
Dolan, J.P.1
Sheppard, B.C.2
Deloughery, T.G.3
-
7
-
-
0345337254
-
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program
-
1:CAS:528:DyaK1cXlsFCgu7c%3D 9704735
-
P McLaughlin AJ Grillo-López BK Link R Levy MS Czuczman ME Williams, et al. 1998 Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program J Clin Oncol 16 2825 2833 1:CAS:528:DyaK1cXlsFCgu7c%3D 9704735
-
(1998)
J Clin Oncol
, vol.16
, pp. 2825-2833
-
-
McLaughlin, P.1
Grillo-López, A.J.2
Link, B.K.3
Levy, R.4
Czuczman, M.S.5
Williams, M.E.6
-
9
-
-
33846918681
-
Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
-
17200219
-
DM Arnold F Dentali MA Crowther RM Meyer RJ Cook C Sigouin, et al. 2007 Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura Ann Intern Med 146 25 33 17200219
-
(2007)
Ann Intern Med
, vol.146
, pp. 25-33
-
-
Arnold, D.M.1
Dentali, F.2
Crowther, M.A.3
Meyer, R.M.4
Cook, R.J.5
Sigouin, C.6
-
10
-
-
33750291236
-
Treatment of pemphigus vulgaris with rituximab and intravenous immuneglobulin
-
1:CAS:528:DC%2BD28XhtFCisLrN 10.1056/NEJMoa062930 17065638
-
AR Ahmed Z Spigelman LA Cavacini MR Posner 2006 Treatment of pemphigus vulgaris with rituximab and intravenous immuneglobulin N Engl J Med 355 1772 1779 1:CAS:528:DC%2BD28XhtFCisLrN 10.1056/NEJMoa062930 17065638
-
(2006)
N Engl J Med
, vol.355
, pp. 1772-1779
-
-
Ahmed, A.R.1
Spigelman, Z.2
Cavacini, L.A.3
Posner, M.R.4
-
11
-
-
70349916130
-
Should low-dose mycophenolate mofetil be used to prolong the response after rituximab therapy in patients with immune thrombocytopenic purpura? A case report
-
1:CAS:528:DC%2BD1MXhtFOju7zP 10.1179/102453309X439782 19635186
-
Q Bruserud K Havardstein 2009 Should low-dose mycophenolate mofetil be used to prolong the response after rituximab therapy in patients with immune thrombocytopenic purpura? A case report Hematology. 14 224 226 1:CAS:528:DC%2BD1MXhtFOju7zP 10.1179/102453309X439782 19635186
-
(2009)
Hematology.
, vol.14
, pp. 224-226
-
-
Bruserud, Q.1
Havardstein, K.2
-
12
-
-
72149125317
-
Clinical applications of intravenous immunoglobulins (IVIg) beyond immunodeficiencies and neurology
-
1:CAS:528:DC%2BD1MXhsFejsbbE 10.1111/j.1365-2249.2009.04024.x 19883421
-
HP Hartung L Mouthon R Ahmed S Jordan KB Laupland S Jolles 2009 Clinical applications of intravenous immunoglobulins (IVIg) beyond immunodeficiencies and neurology Clin Exp Immunol 158 23 33 1:CAS:528:DC%2BD1MXhsFejsbbE 10.1111/j.1365-2249.2009.04024.x 19883421
-
(2009)
Clin Exp Immunol
, vol.158
, pp. 23-33
-
-
Hartung, H.P.1
Mouthon, L.2
Ahmed, R.3
Jordan, S.4
Laupland, K.B.5
Jolles, S.6
-
13
-
-
77950974675
-
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
-
1:CAS:528:DC%2BC3cXkvFKiurc%3D 10.1182/blood-2009-07-229815 20130241
-
F Zaja M Baccarani P Mazza M Bocchia L Gugliotta A Zaccaria, et al. 2010 Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia Blood 115 2755 2762 1:CAS:528:DC%2BC3cXkvFKiurc%3D 10.1182/blood-2009-07-229815 20130241
-
(2010)
Blood
, vol.115
, pp. 2755-2762
-
-
Zaja, F.1
Baccarani, M.2
Mazza, P.3
Bocchia, M.4
Gugliotta, L.5
Zaccaria, A.6
-
14
-
-
64049085194
-
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group
-
1:CAS:528:DC%2BD1MXjsFKhurs%3D 10.1182/blood-2008-07-162503 19005182
-
F Rodeghiero R Stasi T Gernsheimer M Michel D Provan DM Amold, et al. 2009 Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group Blood 113 2386 2393 1:CAS:528:DC%2BD1MXjsFKhurs%3D 10.1182/blood-2008-07-162503 19005182
-
(2009)
Blood
, vol.113
, pp. 2386-2393
-
-
Rodeghiero, F.1
Stasi, R.2
Gernsheimer, T.3
Michel, M.4
Provan, D.5
Amold, D.M.6
-
15
-
-
44949126978
-
Low dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura
-
1:CAS:528:DC%2BD1cXhsVWlur7O 10.3324/haematol.12206 18403395
-
F Zaja ML Battista MT Pirrotta S Palmieri M Montagna N Vianelli, et al. 2008 Low dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura Haematologica 93 930 933 1:CAS:528:DC%2BD1cXhsVWlur7O 10.3324/haematol.12206 18403395
-
(2008)
Haematologica
, vol.93
, pp. 930-933
-
-
Zaja, F.1
Battista, M.L.2
Pirrotta, M.T.3
Palmieri, S.4
Montagna, M.5
Vianelli, N.6
-
16
-
-
33846925496
-
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: A GIMEMA experience
-
1:CAS:528:DC%2BD2sXjt1CgsrY%3D 10.1182/blood-2005-12-015222 17077333
-
MG Mazzucconi P Fazi S Bernasconi G De Rossi G Leone L Gugliotta, et al. 2007 Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience Blood 109 1401 1407 1:CAS:528:DC%2BD2sXjt1CgsrY%3D 10.1182/blood-2005-12-015222 17077333
-
(2007)
Blood
, vol.109
, pp. 1401-1407
-
-
Mazzucconi, M.G.1
Fazi, P.2
Bernasconi, S.3
De Rossi, G.4
Leone, G.5
Gugliotta, L.6
-
17
-
-
66749173745
-
Corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: Patient and hematologist perspectives
-
10.1111/j.1600-0609.2009.01265.x 19374704
-
JA Guidry JN George SK Vesely SM Kennison DR Terrell 2009 Corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives Eur J Haematol 83 175 182 10.1111/j.1600-0609. 2009.01265.x 19374704
-
(2009)
Eur J Haematol
, vol.83
, pp. 175-182
-
-
Guidry, J.A.1
George, J.N.2
Vesely, S.K.3
Kennison, S.M.4
Terrell, D.R.5
-
18
-
-
40949154401
-
Rituximab in the treatment of autoimmune haematological disorders
-
1:CAS:528:DC%2BD1cXlsV2muro%3D 10.1111/j.1365-2141.2008.07054.x 18318765
-
B Garvey 2008 Rituximab in the treatment of autoimmune haematological disorders Br J Haematol 141 149 169 1:CAS:528:DC%2BD1cXlsV2muro%3D 10.1111/j.1365-2141.2008.07054.x 18318765
-
(2008)
Br J Haematol
, vol.141
, pp. 149-169
-
-
Garvey, B.1
-
19
-
-
0032740187
-
Overview of the clinical development of rituximab: First monoclonal antibody approved for the treatment of lymphoma
-
10561020
-
AJ Grillo-López CA White C Varns D Shen A Wei A McClure, et al. 1999 Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma Semin Oncol 26 66 73 10561020
-
(1999)
Semin Oncol
, vol.26
, pp. 66-73
-
-
Grillo-López, A.J.1
White, C.A.2
Varns, C.3
Shen, D.4
Wei, A.5
McClure, A.6
-
20
-
-
34447098797
-
Multistep pathogenesis of autoimmune disease
-
1:CAS:528:DC%2BD2sXotlGmtr0%3D 10.1016/j.cell.2007.06.033 17632054
-
CC Goodnow 2007 Multistep pathogenesis of autoimmune disease Cell 130 25 35 1:CAS:528:DC%2BD2sXotlGmtr0%3D 10.1016/j.cell.2007.06.033 17632054
-
(2007)
Cell
, vol.130
, pp. 25-35
-
-
Goodnow, C.C.1
-
21
-
-
51649091745
-
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
-
1:CAS:528:DC%2BD1cXpvVOktr8%3D 10.1182/blood-2007-12-129262 18375792
-
R Stasi N Cooper G Del Poeta E Stipa M Laura Evangelista E Abruzzese, et al. 2008 Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab Blood 112 1147 1150 1:CAS:528:DC%2BD1cXpvVOktr8%3D 10.1182/blood-2007-12-129262 18375792
-
(2008)
Blood
, vol.112
, pp. 1147-1150
-
-
Stasi, R.1
Cooper, N.2
Del Poeta, G.3
Stipa, E.4
Laura Evangelista, M.5
Abruzzese, E.6
-
22
-
-
62949099499
-
Slow responses to standard dose rituximab in immune thrombocytopenic purpura
-
10.3324/haematol.2008.001396 19252177
-
K Kelly M Glesson PT Murphy 2009 Slow responses to standard dose rituximab in immune thrombocytopenic purpura Haematologica 94 443 444 10.3324/haematol.2008.001396 19252177
-
(2009)
Haematologica
, vol.94
, pp. 443-444
-
-
Kelly, K.1
Glesson, M.2
Murphy, P.T.3
|